Patent Dispute Over Low Testosterone Treatment Briefed For Federal Circuit
WASHINGTON, D.C. — An Indiana federal judge erred in deeming two patents covering a “breakthrough” treatment for hypogonadism invalid, the patent owners recently told the Federal Circuit U.S. Court of Appeals...To view the full article, register now.
Already a subscriber? Click here to view full article